{"name": "TransEnterix",
 "permalink": "transenterix",
 "crunchbase_url": "http://www.crunchbase.com/company/transenterix",
 "homepage_url": "http://www.transenterix.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "other",
 "number_of_employees": null,
 "founded_year": 2006,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@transenterix.com",
 "phone_number": "919-765-8400",
 "description": "",
 "created_at": "Fri Jan 22 12:13:03 UTC 2010",
 "updated_at": "Sat Dec 17 12:25:22 UTC 2011",
 "overview": "\u003Cp\u003ETransEnterix, Inc. operates as a medical-device company which develops minimally invasive laparoscopic surgery platform. Its platform allows a surgeon to remove a patient\u0026#8217;s gall bladder and perform other abdominal surgeries without a scar. The company was founded in 2006 and is based in Durham, North Carolina.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0007/4457/74457v1-max-150x150.jpg"],
     [[185,
       40],
      "assets/images/resized/0007/4457/74457v1-max-250x250.jpg"],
     [[185,
       40],
      "assets/images/resized/0007/4457/74457v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Todd",
      "last_name": "M. Pope",
      "permalink": "todd-m-pope",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "David",
      "last_name": "N. Gill",
      "permalink": "david-n-gill",
      "image": null}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "David",
      "last_name": "Milne",
      "permalink": "david-milne",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-150x150.jpg"],
          [[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-250x250.jpg"],
          [[140,
            140],
           "assets/images/resized/0026/5196/265196v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "director ",
    "person":
     {"first_name": "Andrew",
      "last_name": "Schiff",
      "permalink": "andrew-schiff",
      "image":
       {"available_sizes":
         [[[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-150x150.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-250x250.jpg"],
          [[95,
            144],
           "assets/images/resized/0026/5594/265594v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$70M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://onbiovc.com/transenterix-inc-series-b-55m/",
    "source_description": "TransEnterix, Inc.: Series B $55M",
    "raised_amount": 55000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aisling Capital",
         "permalink": "aisling-capital",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0004/6625/46625v1-max-150x150.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-250x250.png"],
             [[159,
               60],
              "assets/images/resized/0004/6625/46625v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Quaker BioVentures",
         "permalink": "quaker-bioventures",
         "image":
          {"available_sizes":
            [[[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-150x150.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-250x250.jpg"],
             [[144,
               96],
              "assets/images/resized/0004/9249/49249v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Synergy Life Science Partner",
         "permalink": "synergy-life-sciences-partner",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0004/9515/49515v2-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0004/9515/49515v2-max-250x250.jpg"],
             [[322,
               90],
              "assets/images/resized/0004/9515/49515v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Parish Capital Advisors",
         "permalink": "parish-capital-advisors",
         "image":
          {"available_sizes":
            [[[120,
               90],
              "assets/images/resized/0010/3071/103071v1-max-150x150.jpg"],
             [[120,
               90],
              "assets/images/resized/0010/3071/103071v1-max-250x250.jpg"],
             [[120,
               90],
              "assets/images/resized/0010/3071/103071v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.bizjournals.com/triangle/print-edition/2011/12/16/transenterix-raises-15m-bringing-vc.html",
    "source_description": "TransEnterix raises $15M",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 16,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3908 Patriot Drive",
    "address2": "Suite 170",
    "zip_code": "27703",
    "city": "Durham",
    "state_code": "NC",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/4456/74456v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/4456/74456v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/4456/74456v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}